_version_ 1797397076312588288
author Tanuj Puri
Tanuj Puri
Amelia E. Moore
Abhishek Mahajan
Alan McWilliam
Marie H. Vrist
Glen M. Blake
author_facet Tanuj Puri
Tanuj Puri
Amelia E. Moore
Abhishek Mahajan
Alan McWilliam
Marie H. Vrist
Glen M. Blake
author_sort Tanuj Puri
collection DOAJ
first_indexed 2024-03-09T01:05:44Z
format Article
id doaj.art-7888854a6fa84adf9450fa8aa65629c7
institution Directory Open Access Journal
issn 2673-8880
language English
last_indexed 2024-03-09T01:05:44Z
publishDate 2023-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nuclear Medicine
spelling doaj.art-7888854a6fa84adf9450fa8aa65629c72023-12-11T10:08:39ZengFrontiers Media S.A.Frontiers in Nuclear Medicine2673-88802023-12-01310.3389/fnume.2023.13439131343913Editorial: Quantitative [18F]NaF PET in metastatic and metabolic bone diseasesTanuj Puri0Tanuj Puri1Amelia E. Moore2Abhishek Mahajan3Alan McWilliam4Marie H. Vrist5Glen M. Blake6Faculty of Biology, Medicine and Health, School of Medical Sciences, Division of Cancer Sciences, The University of Manchester, The Christie NHS Foundation Trust, Manchester, United KingdomDepartment of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King’s College London, St. Thomas’ Hospital, London, United KingdomDepartment of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King’s College London, St. Thomas’ Hospital, London, United KingdomThe Clatterbridge Cancer Centre NHS Foundation Trust, University of Liverpool, Liverpool, United KingdomFaculty of Biology, Medicine and Health, School of Medical Sciences, Division of Cancer Sciences, The University of Manchester, The Christie NHS Foundation Trust, Manchester, United KingdomGødstrup Hospital, University Clinic in Nephrology and Hypertension, Herning, DenmarkDepartment of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King’s College London, St. Thomas’ Hospital, London, United Kingdomhttps://www.frontiersin.org/articles/10.3389/fnume.2023.1343913/full[18F] sodium fluoride PET-CT[18F]NaF PET-CTquantitative measurement of bonemetastatic bone diseasemetabolic bone diseaseSUV
spellingShingle Tanuj Puri
Tanuj Puri
Amelia E. Moore
Abhishek Mahajan
Alan McWilliam
Marie H. Vrist
Glen M. Blake
Editorial: Quantitative [18F]NaF PET in metastatic and metabolic bone diseases
Frontiers in Nuclear Medicine
[18F] sodium fluoride PET-CT
[18F]NaF PET-CT
quantitative measurement of bone
metastatic bone disease
metabolic bone disease
SUV
title Editorial: Quantitative [18F]NaF PET in metastatic and metabolic bone diseases
title_full Editorial: Quantitative [18F]NaF PET in metastatic and metabolic bone diseases
title_fullStr Editorial: Quantitative [18F]NaF PET in metastatic and metabolic bone diseases
title_full_unstemmed Editorial: Quantitative [18F]NaF PET in metastatic and metabolic bone diseases
title_short Editorial: Quantitative [18F]NaF PET in metastatic and metabolic bone diseases
title_sort editorial quantitative 18f naf pet in metastatic and metabolic bone diseases
topic [18F] sodium fluoride PET-CT
[18F]NaF PET-CT
quantitative measurement of bone
metastatic bone disease
metabolic bone disease
SUV
url https://www.frontiersin.org/articles/10.3389/fnume.2023.1343913/full
work_keys_str_mv AT tanujpuri editorialquantitative18fnafpetinmetastaticandmetabolicbonediseases
AT tanujpuri editorialquantitative18fnafpetinmetastaticandmetabolicbonediseases
AT ameliaemoore editorialquantitative18fnafpetinmetastaticandmetabolicbonediseases
AT abhishekmahajan editorialquantitative18fnafpetinmetastaticandmetabolicbonediseases
AT alanmcwilliam editorialquantitative18fnafpetinmetastaticandmetabolicbonediseases
AT mariehvrist editorialquantitative18fnafpetinmetastaticandmetabolicbonediseases
AT glenmblake editorialquantitative18fnafpetinmetastaticandmetabolicbonediseases